Switch to:
Novo Nordisk A/S (NYSE:NVO)
Accounts Payable
{IF BankInsurance_zone 1}
$1,498 Mil (As of )Jun. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

Novo Nordisk A/Ss quarterly accounts payable declined from Dec. 2015 ($3,001 Mil) to Mar. 2016 ($3,001 Mil) but then increased from Mar. 2016 ($1,284 Mil) to Jun. 2016 ($1,498 Mil)

Novo Nordisk A/Ss quarterly accounts payable increased from Dec. 2013 ($2,810 Mil) to Dec. 2014 ($2,810 Mil) and increased from Dec. 2014 ($2,984 Mil) to Dec. 2015 ($3,001 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


Novo Nordisk A/S Annual Data

Accts Payable 3034044285767387897832,8102,9843,001
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 1,1118201,0652,9841,0511,0781,0773,0011,2841,498

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)